RESUMO
PURPOSE: We investigated quality and efficacy criteria of an autologous, physically and immunologically purified, Newcastle disease virus (NDV)-modified, irradiated tumor-cell vaccine (ATV-NDV) by analyzing three independent cohorts (a through c) of patients vaccinated between 1991 and 1995. MATERIALS AND METHODS: Included were 63 patients with primary breast cancer (a), 27 with metastatic pretreated breast cancer (b), and 31 with metastatic pretreated ovarian cancer (c). In addition to vaccine, cohorts b and c received nonspecific immunotherapy as supportive treatment. After cryoconservation and purification, the vaccines varied in applied numbers of viable cells and dead cell contaminations. We retrospectively hypothesized that an immunogenic vaccine should contain at least 1.5 x 10(6) viable tumor cells and viability should be at least 33%. Each cohort was thus divided into two groups; one that received vaccine type A (A), fulfilling both criteria; and the other type B (B), missing one or both criteria. RESULTS: Conventional prognostic factors were wall balanced between A and B in cohorts a and c. In cohort a, there was a benefit in survival (P = .026) and disease-free survival (P = .089) for A. In addition, in cohort a, the relative risk of dying in the group that received A as compared with B was 0.2 (univariate Cox model). There were also survival trends in favor of A versus B (P = .18 and P = .09, respectively) in cohorts b and c, with relative risks of 0.5 and 0.42, respectively. In cohort b, the survival benefit could not be ascribed to vaccine quality alone, because of prognostic imbalance in favor of A. CONCLUSION: In cohort c, like in cohort a, the survival benefit for A may be ascribed to the ATV-NDV vaccine quality, since prognostic factors were not biased. This could imply clinical effectivity in breast and ovarian cancer with ATV-NDV high-quality vaccine. Furthermore, the data provide clinically relevant information for standardization and quality control of autologous tumor-cell vaccines. A randomized study is urgently needed.
Assuntos
Neoplasias da Mama/terapia , Vacinas Anticâncer/normas , Vírus da Doença de Newcastle/fisiologia , Neoplasias Ovarianas/terapia , Neoplasias da Mama/imunologia , Neoplasias da Mama/patologia , Vacinas Anticâncer/uso terapêutico , Estudos de Coortes , Terapia Combinada , Intervalo Livre de Doença , Feminino , Humanos , Neoplasias Ovarianas/imunologia , Neoplasias Ovarianas/patologia , Prognóstico , Estudos Retrospectivos , Análise de Sobrevida , Resultado do TratamentoRESUMO
This article reports the results of a survey conducted to determine whether critical thinking abilities differ among radiologic technology students educated at the baccalaureate, associate degree and certificate levels. The sample population was 357 students enrolled in radiologic technology programs in Louisiana, Missouri and Oklahoma who completed the Watson-Glaser Critical Thinking Appraisal. Results showed a significant difference in critical thinking abilities at the three educational levels. Baccalaureate students scored significantly higher in critical thinking abilities than associate and certificate students, and certificate students scored significantly higher than associate degree students.
Assuntos
Estudantes , Tecnologia Radiológica/educação , Pensamento , Adulto , Análise de Variância , Escolaridade , Feminino , Humanos , Louisiana , Masculino , Pessoa de Meia-Idade , Missouri , Oklahoma , Reprodutibilidade dos TestesRESUMO
The widths of foetal lateral ventricles and hemispheres were measured in 197 normal pregnancies in addition to routine ultrasound foetometry between the 12th and 40th weeks of gestation. The 95% confidence intervals of foetal lateral ventricle hemisphere ratios were calculated by means of regression analysis. The mean value for the occipital horn hemisphere ratio was 0.57 in the 12th week of gestation and 0.21 in the 40th week of gestation. The mean value of frontal horn hemisphere ratio was 0.41 in the 12th week of gestation and 0.18 in the 40th week of gestation. Values exceeding the upper limit of 95% confidence interval are indicative of early development of foetal hydrocephalus and should be followed by further foetal investigations.
Assuntos
Ventrículos Cerebrais/embriologia , Hidrocefalia/embriologia , Ventrículos Cerebrais/diagnóstico por imagem , Dominância Cerebral/fisiologia , Feminino , Idade Gestacional , Humanos , Hidrocefalia/diagnóstico por imagem , Recém-Nascido , Gravidez , Valores de Referência , Análise de Regressão , Ultrassonografia Pré-NatalRESUMO
PURPOSE: The purpose of this study was to evaluate the impact of [18F]fluorodeoxy-D-glucose positron emission tomography (FDG-PET) on the primary staging of patients with small-cell lung cancer (SCLC). METHODS: FDG-PET was performed in 120 consecutive patients with SCLC during primary staging. In addition, brain examinations with both FDG-PET and cranial magnetic resonance imaging (MRI) or computed tomography (CT) were performed in 91 patients. Results of FDG-PET were compared with those of conventional staging procedures. FDG-PET detected markedly increased FDG uptake in the primary tumours of all 120 patients (sensitivity 100%). RESULTS: Complete agreement between FDG-PET results and other staging procedures was observed in 75 patients. Differences occurred in 45 patients at 65 sites. In 47 sites the FDG-PET results were proven to be correct, and in ten, incorrect. In the remaining eight sites, the discrepancies could not be clarified. In 14/120 patients, FDG-PET caused a stage migration, correctly upstaging ten patients to extensive disease and downstaging three patients by not confirming metastases of the adrenal glands suspected on the basis of CT. Only 1/120 patients was incorrectly staged by FDG-PET, owing to failure to detect brain metastases. In all cases the stage migration led to a significant change in the treatment protocol. Sensitivity of FDG-PET was significantly superior to that of CT in the detection of extrathoracic lymph node involvement (100% vs 70%, specificity 98% vs 94%) and distant metastases except to the brain (98% vs 83%, specificity 92% vs 79%). However, FDG-PET was significantly less sensitive than cranial MRI/CT in the detection of brain metastases (46% vs 100%, specificity 97% vs 100%). CONCLUSION: The introduction of FDG-PET in the diagnostic evaluation of SCLC will improve the staging results and affect patient management, and may reduce the number of tests and invasive procedures.